Nachrichten zur Cerevel Therapeutics Hld. Inc. Aktie

The biotech sector is a dynamic and constantly evolving industry that is driving scientific advancements and innovation in healthcare. According…

AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.…

Abbvie Inc (NYSE:ABBV) announced late Wednesday an agreement to acquire neuroscience drugmaker Cerevel Therapeutics for $45 per share in cash, or…

AbbVie (ABBV) offers to buy Cerevel Therapeutics (CERE) for $8.7 billion. The acquisition will strengthen AbbVies neuroscience pipeline.…

AbbVie enters agreement to acquire Cerevel Therapeutics…

The deal is AbbVies latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic…

AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal…

AbbVie Inc. said late Wednesday it has agreed to buy Cerevel Therapeutics Holdings Inc. for $8.7 billion, saying that Cerevels…

…

…

CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to…

CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to…

Coles, N Anthony - Vorstand - Tag der Transaktion: 2023-06-01...…

Bodenrader, Mark - Vorstand - Tag der Transaktion: 2023-06-02...…

Coles, N Anthony - Vorstand - Tag der Transaktion: 2023-04-11...…

Coles, N Anthony - Vorstand - Tag der Transaktion: 2023-02-07...…

Coles, N Anthony - Vorstand - Tag der Transaktion: 2023-01-05...…